Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering (Q38959564)
Jump to navigation
Jump to search
scientific article published on 18 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering |
scientific article published on 18 September 2014 |
Statements
1 reference
Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering (English)
1 reference
Thomas H Pillow
Janet Tien
Kathryn L Parsons-Reponte
Sunil Bhakta
Hao Li
Leanna R Staben
Guangmin Li
Josefa Chuh
Aimee Fourie-O'Donohue
Martine Darwish
Victor Yip
Luna Liu
Douglas D Leipold
Dian Su
Elmer Wu
Susan D Spencer
Ben-Quan Shen
Keyang Xu
Katherine R Kozak
Helga Raab
Richard Vandlen
Gail D Lewis Phillips
Richard H Scheller
Paul Polakis
Mark X Sliwkowski
18 September 2014
1 reference